BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19396735)

  • 1. Pooling in high-throughput drug screening.
    Kainkaryam RM; Woolf PJ
    Curr Opin Drug Discov Devel; 2009 May; 12(3):339-50. PubMed ID: 19396735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. poolHiTS: a shifted transversal design based pooling strategy for high-throughput drug screening.
    Kainkaryam RM; Woolf PJ
    BMC Bioinformatics; 2008 May; 9():256. PubMed ID: 18513431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Just-in-Time Compound Pooling Increases Primary Screening Capacity without Compromising Screening Quality.
    Elkin LL; Harden DG; Saldanha S; Ferguson H; Cheney DL; Pieniazek SN; Maloney DP; Zewinski J; O'Connell J; Banks M
    J Biomol Screen; 2015 Jun; 20(5):577-87. PubMed ID: 25722344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Pools of Compounds against Multiple Endogenously Expressed Targets in a Chemoproteomics Binding Assay.
    Salzer E; Nixon E; Drewes G; Reinhard F; Bergamini G; Rau C
    J Lab Autom; 2016 Feb; 21(1):133-42. PubMed ID: 26169024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-throughput Screening Technology for Selective Inhibitors of Transporters and Its Application in Drug Discovery].
    Motoyaji T
    Yakugaku Zasshi; 2021; 141(4):511-515. PubMed ID: 33790118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular library design using multi-objective optimization methods.
    Nicolaou CA; Kannas CC
    Methods Mol Biol; 2011; 685():53-69. PubMed ID: 20981518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technological advances in high-throughput screening.
    Liu B; Li S; Hu J
    Am J Pharmacogenomics; 2004; 4(4):263-76. PubMed ID: 15287820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel miniaturized systems in high-throughput screening.
    Battersby BJ; Trau M
    Trends Biotechnol; 2002 Apr; 20(4):167-73. PubMed ID: 11906749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Library Design.
    Ashenden SK
    Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
    Dreiman GHS; Bictash M; Fish PV; Griffin L; Svensson F
    SLAS Discov; 2021 Feb; 26(2):257-262. PubMed ID: 32808550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconvolution of combinatorial libraries for Drug discovery: theoretical comparison of pooling strategies.
    Konings DA; Wyatt JR; Ecker DJ; Freier SM
    J Med Chem; 1996 Jul; 39(14):2710-9. PubMed ID: 8709101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
    Roy A; McDonald PR; Sittampalam S; Chaguturu R
    Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial drug discovery in nanoliter droplets.
    Kulesa A; Kehe J; Hurtado JE; Tawde P; Blainey PC
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6685-6690. PubMed ID: 29899149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A sandwiched microarray platform for benchtop cell-based high throughput screening.
    Wu J; Wheeldon I; Guo Y; Lu T; Du Y; Wang B; He J; Hu Y; Khademhosseini A
    Biomaterials; 2011 Jan; 32(3):841-8. PubMed ID: 20965560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
    J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic pooling of compounds for high-throughput screening.
    Hann M; Hudson B; Lewell X; Lifely R; Miller L; Ramsden N
    J Chem Inf Comput Sci; 1999; 39(5):897-902. PubMed ID: 10529988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening normalized to biological response: application to antiviral drug discovery.
    Patel DA; Patel AC; Nolan WC; Huang G; Romero AG; Charlton N; Agapov E; Zhang Y; Holtzman MJ
    J Biomol Screen; 2014 Jan; 19(1):119-30. PubMed ID: 23860224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.